Regeneron's Phase III trial investigated cemdisiran and pozelimab as both monotherapies and in combination in gMG.

Advancing a neuromuscular franchise with claseprubart, a highly potent investigational classical pathway inhibitor, across generalized Myasthenia Gravis (gMG), Multifocal Motor Neuropathy (MMN) and ...

Discover practical, expert-recommended home modifications that can help reduce fatigue and prevent injury in people living ...

With treatment, myasthenia gravis can generally be controlled. In fact, about 50 percent of people who have their thymus gland removed may experience long-lasting, complete remission of myasthenia ...

Don't let myasthenia gravis keep you from exploring. Learn expert tips on managing fatigue, choosing accessible lodging, ...

Find effective medications for 'Myasthenia Gravis treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed to manage ...

A myasthenic crisis is a life-threatening complication of myasthenia gravis. It’s when the muscles that you use to breathe get so weak that you can’t get air in and out of your lungs. It isn’t the ...

The FDA has granted Priority Review to cemdisiran, a subcutaneously administered siRNA targeting C5 for anti-AChR antibody-positive generalized myasthenia gravis.

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...